Navigation Links
Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
Date:11/4/2008

- Company Also Announces Participation in Upcoming Investor Conferences in

November -

SAN DIEGO, Nov. 4 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity and other central nervous system-related disorders, today announced its active calendar of events for November 2008, which includes the teleconference and webcast of its third quarter 2008 financial results as well as upcoming corporate presentations at noteworthy investor conferences.

On November 6, 2008 at 5:00 p.m. Eastern time, Orexigen management will host the call and webcast to discuss the financial results for the third quarter ended September 30, 2008, and recent business highlights. The live call may be accessed by calling 800-860-2442 (domestic) or 412-858-4600 (international). The webcast can be accessed live on the investor relations section of the Company's web site at http://www.orexigen.com and will be archived for 14 days following the call.

Upcoming Corporate Presentations

Rodman & Renshaw 10th Annual Healthcare Conference

New York Palace Hotel, New York

November 11, 2008

2:00 p.m. EST

Lazard Capital Markets 5th Annual Healthcare Conference

St. Regis Hotel, New York

November 18, 2008

11:25 a.m. EST

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity and other central nervous system-related disorders. The Company's lead combination product candidates targeted for obesity are Contrave, which is in Phase 3 clinical trials, and Empatic, which is
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
2. Cell Therapeutics, Inc. (CTI) Oppenheimer & Co. Healthcare Conference Presentation to be Webcast
3. Arno Therapeutics Appoints William F. Hamilton to Board of Directors
4. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
5. Duska Therapeutics Acquires Technology for ATPotent Sperm Motility Program
6. ConvaTec Names Presidents of Wound Therapeutics and Ostomy Care Business Units
7. Preliminary Clinical Data Presented at the 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics Demonstrate Superior Profile of S*BIOs Novel Anti-Cancer Drug SB939
8. Synvista Therapeutics Appoints William Federici to its Board of Directors
9. LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster
10. Cell Therapeutics Regains Compliance with NASDAQs Minimum Bid Price Requirement
11. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... , Fast food chains are o...obesity. A recent poll by Fitness.com.au however f...shoulder the responsibility. , ...ast food chains, and video games were behind Austr...nd Dad are more than just innocent bystanders. A r...
(Date:11/9/2009)... , New study highlights p...health , Rosemont, IL (Vo...ncrease and bone health decreases. Recent research...lcium supplements to help prevent these issues. Ho...ber issue of Sports Health: A Multidisciplinary A...
(Date:11/9/2009)... , LEBANON, Tenn., Nov. 9 Hea...oday announced it will host their inaugural Hospit...3-15, 2010 at the Marriott Renaissance Hotel in Na...pecting more than 100 hospital operating room dire...als and health systems in the country. Some of the...
(Date:11/9/2009)... , DETROIT, Nov. 9 ...armanos Cancer Center has been selected the most p...higan, according to a survey by the National Resea...m.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) ,, ...uestionnaire between September 2008 and August 200...
(Date:11/9/2009)... Study didn,t answer question of why this is so, ...News) -- After a lumpectomy, women with very dense...n the affected breast, a new study shows. , Bre...sed risk of developing breast cancer, and experts ... associated with an increased risk of cancer recur...
Breaking Medicine News(10 mins):Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3
... Eve , , ROCKVILLE, Md., Dec. 16 Some New Ye...or example, more people are likely to die in alcoh...on other mid-week winter evenings. , , (Photo...ministration statistics shows that, by the time ou...
...at the 27th Annual J.P. Morgan Healthcare Conferen...xecutive vice president, finance and chief,financi... company at noon,Central time. , A live audi... of the presentation will be available later that ...
...second Indiana Planned Parenthood clinic shows an ...rs evade their legal responsibility to report the ...the second video in Live Action Film,s "Mona Lisa ...undercover this summer at a Planned Parenthood in ...
...day the five grand prize winners of the 2008 WEIG... All five grand prize winners are living proof th...nges in other areas of life. Their Inspiring Stori...inner is featured on the cover of Good Housekeepi...
...nc., a subsidiary of SAP AG (NYSE: SAP ), today ...ted and implemented SAP(R) solutions to more,effec...healthcare system in,the areas of financials and p...rise applications to help achieving newly,establis...
...,the company,s Enterprise (formerly TouchWorks(R))...1 product in its market segment for the second yea.... In its closely watched 2008,Top 20 Best in KLAS...ng hospital market segment. , (Logo: http:/...
Other Medicine News:Health News:New Year, Old Myths, New Fatalities 2Health News:New Year, Old Myths, New Fatalities 3Health News:Abuse Pattern Develops as Second Indiana Planned Parenthood Covers Up Statutory Rape of 13-Year-Old 2Health News:Weight Watchers(R) Reveals the 2008 Inspiring Stories of the Year Contest Winners Online and in the January Issue of Good Housekeeping 2Health News:Weight Watchers(R) Reveals the 2008 Inspiring Stories of the Year Contest Winners Online and in the January Issue of Good Housekeeping 3Health News:Weight Watchers(R) Reveals the 2008 Inspiring Stories of the Year Contest Winners Online and in the January Issue of Good Housekeeping 4Health News:Weight Watchers(R) Reveals the 2008 Inspiring Stories of the Year Contest Winners Online and in the January Issue of Good Housekeeping 5Health News:Weight Watchers(R) Reveals the 2008 Inspiring Stories of the Year Contest Winners Online and in the January Issue of Good Housekeeping 6Health News:SAP Provides Prescription for Success to MetroSouth Medical Center 2Health News:SAP Provides Prescription for Success to MetroSouth Medical Center 3Health News:SAP Provides Prescription for Success to MetroSouth Medical Center 4Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 2Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 3Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 4
(Date:11/9/2009)...swire/ -- Access MediQuip, LLC, the nation,s first...dical device management solutions to the healthcar...its corporate headquarters to Lake Mary, Florida. ...growth, includes a major expansion of the Primera ...uary 2010 and relocation and expansion of the Hous...
(Date:11/9/2009)...tCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: IST...ompany,s Bepreve(TM) (bepotastine besilate ophthal...e results were presented in poster sessions at the...lergy, Asthma & Immunology (ACAAI) in Miami Be...Treatment of Ocular Itching with Bepotastine Besil...
(Date:11/9/2009)...wswire/ -- Thomson Reuters today announced the n...eading clinical surveillance solution that enables...me and respond immediately to improve clinical qua...s upgrade is available to current CareFocus custom...ontains several powerful enhancements that improve...
Breaking Medicine Technology:Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Proteins in gel 8982 1PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 1PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 2PHT Names VP to Lead Sales of A Claim Payment Solution for Doctors Hospitals 49924 1PHT Names VP to Lead Sales of A Claim Payment Solution for Doctors Hospitals 49924 2
...stent may hold clinical edge over Taxus stent at t..., March 31 Early results of the SPIRIT II study,s...Taxus stent in six-month,findings on angiography a...ow, a new analysis shows that after two years, the... may continue to hold a clinical edge over,its pac...
...any,s TAXUS(R) and PROMUS(TM) Stents demonstrate p...mes, NATICK, Mass. and CHICAGO, March 31 Boston,...d positive two-year results,from Abbott,s prospect...ty,SPIRIT II Trial comparing the safety and effica...ting Coronary Stent and Boston Scientific,s,worldw...
Other Medicine Technology:SPIRIT II Explores Long-Term Performance of XIENCE V Stent 2SPIRIT II Explores Long-Term Performance of XIENCE V Stent 3Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 2Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 3Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 4
... make us a leader in this field. With standard ass...laboratory, our Infectious Disease ELISA products ...stency. Our Infectious Disease ELISA menu includes...ological assays including ToRCH, EBV, H. pylori an...
C. Diff-CHEK-30
TOX A/B QUIK CHEK
...e single-well ANA screen and ENA screen ELISAs, as...d 6 individual ENA kits: Sm, Sm/RNP, SS-A (Ro), SS...une ELISA family includes a full line of products ...hyroid Microsomal, MPO, PR3, Rheumatoid Factor and...
Medicine Products: